Patents by Inventor Halcyon G. Skinner

Halcyon G. Skinner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for detecting risk of fatal prostate cancer using serum calcium
    Patent number: 9470697
    Abstract: A method of screening for increased risk of fatal prostate cancer in a subject comprises providing a blood sample collected from the subject, and then detecting the presence or absence of an increased level of serum calcium in the sample. An increased level of serum calcium indicates the subject is at increased risk of fatal prostate cancer.
    Type: Grant
    Filed: September 24, 2014
    Date of Patent: October 18, 2016
    Assignee: Wake Forest University Health Services
    Inventors: Gary G. Schwartz, Halcyon G. Skinner
  • METHODS FOR DETECTING RISK OF FATAL PROSTATE CANCER USING SERUM CALCIUM
    Publication number: 20150010934
    Abstract: A method of screening for increased risk of fatal prostate cancer in a subject comprises providing a blood sample collected from the subject, and then detecting the presence or absence of an increased level of serum calcium in the sample. An increased level of serum calcium indicates the subject is at increased risk of fatal prostate cancer.
    Type: Application
    Filed: September 24, 2014
    Publication date: January 8, 2015
    Inventors: Gary G. Schwartz, Halcyon G. Skinner
  • Methods for detecting risk of fatal prostate cancer using serum calcium
    Patent number: 8871458
    Abstract: A method of screening for increased risk of fatal prostate cancer in a subject comprises providing a blood sample collected from the subject, and then detecting the presence or absence of an increased level of serum calcium in the sample. An increased level of serum calcium indicates the subject is at increased risk of fatal prostate cancer.
    Type: Grant
    Filed: December 22, 2009
    Date of Patent: October 28, 2014
    Assignee: Wake Forest University Health Sciences
    Inventors: Gary G. Schwartz, Halcyon G. Skinner
  • METHODS FOR DETECTING RISK OF FATAL PROSTATE CANCER USING SERUM CALCIUM
    Publication number: 20100167325
    Abstract: A method of screening for increased risk of fatal prostate cancer in a subject comprises providing a blood sample collected from the subject, and then detecting the presence or absence of an increased level of serum calcium in the sample. An increased level of serum calcium indicates the subject is at increased risk of fatal prostate cancer.
    Type: Application
    Filed: December 22, 2009
    Publication date: July 1, 2010
    Inventors: Gary G. Schwartz, Halcyon G. Skinner